GENEVA, July 31 -- SANARE PHARMACEUTICALS filed a patent application (US2026/012683) for “COMBINATIONS OF SGLT2 INHIBITORS AND ANTIOXIDANTS AND THEIR USES”. With publication no. WO/2026/161855, here are the other details related to the patent application:
Kind: Initial Publication without ISR [A2]
IPC: A61K 31/7034
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....